Healthcare >> CEO Interviews >> October 12, 2001
LISSA A. GOLDENSTEIN has served as President, Chief Operating Officer
and Board member of Argonaut Technologies, Inc., since April 2001.
Previously, she served as Sr. Vice President and Chief Business Officer
from August 2000. From January 1998 until August 2000, she served as our
Vice President, Sales and Marketing. From January 1994 to December 1997,
Ms. Goldenstein was Senior Vice President, Worldwide Sales with
Molecular Simulations, a provider of molecular modeling and simulation
software for life and materials science research. While at Molecular
Simulation Incorporated, Ms. Goldenstein was President of Teijin
Molecular Simulations, a joint venture in Tokyo, which managed Molecular
Simulation's business in Japan and the Asia Pacific markets. Ms.
Goldenstein has a BS in Architectural Engineering from Pennsylvania
State University and received her Professional Engineers license as a
Civil Engineer in the State of California in 1981. Profile
TWST: Can we start out with a history and overview of ArgonautTechnologies?
Ms. Goldenstein: Argonaut Technologies is approximately seven years old.
We started in the 'early days' when